---
title: "$100 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297569372.md"
description: "Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past five years with an annualized return of 33.55%. A $100 investment made five years ago would now be worth $415.68, based on a current stock price of $35.25. The company currently holds a market capitalization of $6.12 billion."
datetime: "2026-08-31T22:30:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297569372.md)
  - [en](https://longbridge.com/en/news/297569372.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297569372.md)
generator: "portal-rs"
---

# $100 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Today

Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 22.44% on an annualized basis producing an average annual return of 33.55%. Currently, Cogent Biosciences has a market capitalization of $6.12 billion.

**Buying $100 In COGT:** If an investor had bought $100 of COGT stock 5 years ago, it would be worth **$415.68** today based on a price of $35.25 for COGT at the time of writing.

### Cogent Biosciences’s Performance Over Last 5 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/08/31/d9046c13b3e3f48740dc7fb367392ed9.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

*This article was generated by Benzinga's automated content engine and reviewed by an editor.*

### Related Stocks

- [COGT.US](https://longbridge.com/en/quote/COGT.US.md)

## Related News & Research

- [Cogent Biosciences files for USD 400 million at-the-market stock offering](https://longbridge.com/en/news/295453309.md)
- [Cogent Biosciences Secures Long-Term Bezuclastinib Supply Deal](https://longbridge.com/en/news/297839428.md)
- [260,508 Shares in Kraft Heinz Company $KHC Purchased by Corecam Pte. Ltd.](https://longbridge.com/en/news/302982090.md)
- [The Campbell's Company $CPB Stock Holdings Boosted by Nisa Investment Advisors LLC](https://longbridge.com/en/news/302982731.md)
- [7,129 Johnson & Johnson $JNJ Shares Sold by Smith Chas P & Associates PA Cpas](https://longbridge.com/en/news/302983370.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**